Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeTax ProvisionsTax Rate
Others
Ratios

Cryo Cell International (CCEL) EBT (2016 - 2025)

Historic EBT for Cryo Cell International (CCEL) over the last 16 years, with Q3 2025 value amounting to $1.2 million.

  • Cryo Cell International's EBT fell 1404.99% to $1.2 million in Q3 2025 from the same period last year, while for Aug 2025 it was $1.5 million, marking a year-over-year increase of 11176.35%. This contributed to the annual value of $2.8 million for FY2024, which is 12098.19% up from last year.
  • As of Q3 2025, Cryo Cell International's EBT stood at $1.2 million, which was down 1404.99% from $575103.0 recorded in Q2 2025.
  • Cryo Cell International's 5-year EBT high stood at $1.6 million for Q2 2021, and its period low was -$16.0 million during Q4 2023.
  • Moreover, its 5-year median value for EBT was $899780.0 (2022), whereas its average is -$122914.6.
  • As far as peak fluctuations go, Cryo Cell International's EBT crashed by 266913.29% in 2023, and later surged by 32497.58% in 2024.
  • Quarter analysis of 5 years shows Cryo Cell International's EBT stood at -$1.2 million in 2021, then surged by 150.05% to $622508.0 in 2022, then tumbled by 2669.13% to -$16.0 million in 2023, then surged by 94.73% to -$842434.0 in 2024, then soared by 240.78% to $1.2 million in 2025.
  • Its EBT was $1.2 million in Q3 2025, compared to $575103.0 in Q2 2025 and $533718.0 in Q1 2025.